Clinical Trial Update: The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine [Phase 3]

View source ↗

Summary

This report covers a Phase 3 trial evaluating topiramate for prevention of chronic migraine. It summarizes the effectiveness and safety findings from the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Migraine | Phase 3 | Status: COMPLETED